Exosome-Based Diagnostics and Cell-Free Therapeutics for Traumatic Brain Injury: From Mechanisms to Bedside.

Over the 18-week observation period, although gains in cognition and spasticity did not reach statistical significance, the FIM motor scores and global quality of life improved significantly. 159 Both studies had small sample sizes and lacked randomized controls, but they undeniably accelerated the clinical transformation of exosome treatment regimens.

also in 111,027 other papers